Latest filing published 24 Sept 2026 for IMPACT BIOMEDICAL INC., €347. Read the official filing
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by DSS, Inc. span 2 companies, the busiest being SHARING SERVICES GLOBAL Corp and Impact Biomedical Inc. Over a trading history stretching from 29 September 2021 to 24 September 2026, the count stands at 27 filings.
Both buying and selling appear: 15 purchases worth €137k, against 10 sales worth €1.4M. On balance, insiders were net sellers of €1.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 share grants. So far in 2026, the count stands at no purchases and 4 sales.
The median purchase comes to €857. 6 out of 15 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 24 September 2026, reports an open-market sale of €967 in Impact Biomedical Inc. The clock since the last published purchase (19 September 2024) now reads 759 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations